Bibliographia Aethiopica II

Bibliographia Aethiopica II

Author: Hans Wilhelm Lockot

Publisher: Otto Harrassowitz Verlag

Published: 1998

Total Pages: 890

ISBN-13: 9783447036115

DOWNLOAD EBOOK

Erstmals wird hier die Fulle der englischsprachigen Athiopienliteratur geordnet dargeboten. In 100 Sections fuhrt der Autor alle fur die wissenschaftliche Beschaftigung mit Athiopien wichtigen Buch- und Zeitschriftenbeitrage zum Beispiel zur "Historyof Research", "Archaeology", "Religion", aber auch Fragen der "Sociology", "Agriculture", "Zoology" und "Medical Sciences" auf. Wie im Falle der deutschsprachigen Literatur ("Bibliographia Aethiopica: Die athiopienkundliche Literatur des deutschsprachigenRaumes" = Aethiopistische Forschungen 9 [1982]) berucksichtigt der Autor auch alle ihm zuganglichen Besprechungen, womit bei einer Aufnahme von mehr als 24.000 Titeln eine Art "Bibliographic Enzyclopedia" entstanden ist.


Drugs and Pharmaceutical Industry

Drugs and Pharmaceutical Industry

Author: D. K. Mittal

Publisher:

Published: 1993

Total Pages: 278

ISBN-13:

DOWNLOAD EBOOK

Growth Of Drugs And Pharmaceutical Industry Is Crucial To The Health Care Of People In A Country Where Despite High Incidence Of Disease The Per Capita Expenditure On Drugs Is Less Than 5 Per Cent Of That In Many Developed Countries. The Basic Thrust Of Drugs And Pharmaceuticals Policy In India Is, Therefore, To Make Adequate Quantity Of Quality Drugs Available To The Poor Masses At Affordable Prices.Despite The Rigid Control By The Government In Respect Of Product-Mix, Pricing Of Bulk Drugs And Formulations And Profitability Of Producing Enterprises, The Indian Drugs And Pharmaceutical Industry Has Grown Significantly, Though Not Sufficiently, Since Independence. Production Of Formulations Increased From A Mere Rs. 35 Crore In 1952 To Rs. 3600 Crore In 1990-91 And That Of Bulk Drugs Increased From Rs.15 Crore In 1962 To Rs.700 Crore In 1990-91. Even Then, With 15 Per Cent Of World Population, India Is Producing Only 2 Per Cent Of World Drug Production. Production Generally Lagged Behind The Plan Targets Mainly Due To Rigid Controls On The Industry.Preventing Profiteering In An Industry Which Produces For Basic Health Care Of The People Is Unobjectionable, But Simultaneously The Price Of Essential Drugs Required On A Large Scale Should Be Remunerative Enough, So That Consumer Protection Is Ensured All Round In Terms Of Availability, Quality And Price. An Attempt To Keep Control Prices Of Drugs Low Has Sharply Eroded The Industry S Earnings Even Below The Level Prescribed By The Government And Drove Many Companies To Diversify Into Non-Pharma Activities. In The Process, Several Critical Drugs Needed By The Common Man Could Not Be Indigenously Produced In Sufficient Quantities. The Shortages Emerged And Large Scale Imports Were Resorted To. The Present Study Relating To Production, Consumption, Import/Export, R&D, Pricing And Profitability Of The Public And Private Sector Drugs And Pharmaceutical Industry Has Been Supplemented With 50 Tables And Official Reports/Orders Such As Kelkar Committee Reports, Dpco 1987 Etc.


Report

Report

Author: United Nations Conference on Trade and Development. Trade and Development Board

Publisher:

Published: 1985

Total Pages: 108

ISBN-13:

DOWNLOAD EBOOK